| Knowledge4COVID-19

Property	Value
is ?:annotates of	<https://research.tib.eu/covid-19/entity/34376387_HAS_TOPIC_C0041703> <https://research.tib.eu/covid-19/entity/34376387_HAS_TOPIC_C0042196> <https://research.tib.eu/covid-19/entity/34376387_HAS_TOPIC_C0042210> <https://research.tib.eu/covid-19/entity/34376387_HAS_TOPIC_C0086418> <https://research.tib.eu/covid-19/entity/34376387_HAS_TOPIC_C0205991> <https://research.tib.eu/covid-19/entity/34376387_HAS_TOPIC_C0206082> <https://research.tib.eu/covid-19/entity/34376387_HAS_TOPIC_C0242456> <https://research.tib.eu/covid-19/entity/34376387_HAS_TOPIC_C1615608> <https://research.tib.eu/covid-19/entity/34376387_HAS_TOPIC_C4279931> <https://research.tib.eu/covid-19/entity/34376387_HAS_TOPIC_C4279932> <https://research.tib.eu/covid-19/entity/34376387_HAS_TOPIC_C4279933> <https://research.tib.eu/covid-19/entity/34376387_HAS_TOPIC_C5203670> <https://research.tib.eu/covid-19/entity/34376387_HAS_TOPIC_C5203676> <https://research.tib.eu/covid-19/entity/34376387_HAS_TOPIC_C5387588> <https://research.tib.eu/covid-19/entity/34376387_HAS_TOPIC_C5392141>
?:authorAffiliation	[\'Merck & Co, Inc, Kenilworth, New Jersey ava.skolnik@merck.com.\', \'Merck & Co, Inc, Kenilworth, New Jersey.\']
?:citedBy	-1
?:creator	<https://research.tib.eu/covid-19/entity/Bhatti_Alexandra> <https://research.tib.eu/covid-19/entity/Larson_Anna> <https://research.tib.eu/covid-19/entity/Mitrovich_Rachel> <https://research.tib.eu/covid-19/entity/Skolnik_Ava>
?:doi	<https://research.tib.eu/covid-19/entity/10.1370/afm.2730>
?:doi	10.1370/afm.2730
?:hasPublicationType	<https://research.tib.eu/covid-19/entity/Journal_Article>
?:journal	Annals of family medicine
is ?:pmid of	<https://research.tib.eu/covid-19/entity/34376387>
?:pmid	<https://research.tib.eu/covid-19/entity/34376387>
?:pmid	34376387
?:publication_isRelatedTo_Disease	<https://research.tib.eu/covid-19/entity/Covid-19>
?:rankingScore_SJR	2.748
?:rankingScore_hIndex	95
?:title	Silent Consequences of COVID-19: Why It\'s Critical to Recover Routine Vaccination Rates Through Equitable Vaccine Policies and Practices.
?:type	<https://research.tib.eu/covid-19/vocab/Publication> <https://research.tib.eu/covid-19/vocab/Publication_Author>

Metadata

Anon_0

<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>

<http://purl.org/net/provenance/ns#DataItem>

<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>

<http://www.w3.org/2004/03/trix/rdfg-1/Graph>

<http://xmlns.com/foaf/0.1/primaryTopic>

<https://research.tib.eu/covid-19/entity/34376387>

<http://xmlns.com/foaf/0.1/topic>

Anon_0

<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes>

<https://research.tib.eu/covid-19/data/entity/34376387>

<http://purl.org/net/provenance/ns#createdBy>

Anon_1 (more)

expand all